CLINICAL TRIAL: CBT AUGMENTATION OF SSRI TREATMENT FOR GERIATRIC GAD

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 56周多中心研究，关于认知行为疗法作为对艾司匹兰部分或完全有效的患有广泛性焦虑障碍的老年人的增强和维持策略的有效性，以及维持艾司西普兰预防复发的有效性。目的是研究增加一个疗程的CBT是否会增加缓解率和症状反应的结果，并改善对依西他普兰部分有效的GAD老年患者的神经心理功能。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 56 week multicenter study on the efficacy of Cognitive-Behavioral Therapy as an augmentation and maintenance strategy for older adults with Generalized Anxiety Disorder who are partial or full responders to escitalopram and also on the efficacy of maintenance escitalopram to prevent relapse. Goals are to examine whether adding a course of CBT will increase remission rates and reult in sympotomatic response and improved neuropsychological functioning among older adults with GAD who are partial responders to escitalopram.